Loading provider…
Loading provider…
Gastroenterology Physician in Glen Burnie, MD
NPI: 1336283720Primary Practice Location
UNIVERSITY OF MD BALTIMORE WASHINGTON MEDICAL CENTER
301 Hospital Dr, Glen Burnie, MD
Primary Employer
Woodholme Gastroenterology Associates
woodholmegi.com
HQ Phone
Get M.D., PH.D. Kenolisa's Phone Numberphone_androidMobile
Get M.D., PH.D. Kenolisa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 140 | 140 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 105 | 136 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 83 | 85 |
| 4 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 70 | 71 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 66 | 73 |
Authors: Chavadi, Sivagami Sundaram, Onwueme, Kenolisa C, Edupuganti, Uthamaphani R, Jerome, Jeff, Chatterjee, Delphi, Soll, Clifford E, Quadri, Luis E N
Journal: Microbiology (Reading)
Publication Date: 2012-02-23
High prevalence of toxinogenic Clostridium difficile in Nigerian adult HIV patients.
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab